Therapeutic inhibition of ferroptosis in ...
Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
Permalink :
Title :
Therapeutic inhibition of ferroptosis in neurodegenerative disease.
Author(s) :
Ryan, Sean K. [Auteur]
Ugalde, Cathryn L. [Auteur]
Rolland, Anne-Sophie [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Skidmore, John [Auteur]
Devos, David [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Hammond, Timothy R. [Auteur]
Ugalde, Cathryn L. [Auteur]
Rolland, Anne-Sophie [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Skidmore, John [Auteur]
Devos, David [Auteur]

Lille Neurosciences & Cognition (LilNCog) - U 1172
Hammond, Timothy R. [Auteur]
Journal title :
Trends in Pharmacological Sciences
Volume number :
44
Pages :
674-688
Publication date :
2023-09-03
ISSN :
1873-3735
English keyword(s) :
ferroptosis
neurodegeneration
Parkinson's
Alzheimer's
drug discovery
iron
inhibitor
treatment
therapeutics
lipid peroxidation
ALS
neurodegeneration
Parkinson's
Alzheimer's
drug discovery
iron
inhibitor
treatment
therapeutics
lipid peroxidation
ALS
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Iron accumulation has been associated with the etiology and progression of multiple neurodegenerative diseases (NDDs). The exact role of iron in these diseases is not fully understood, but an iron-dependent form of regulated ...
Show more >Iron accumulation has been associated with the etiology and progression of multiple neurodegenerative diseases (NDDs). The exact role of iron in these diseases is not fully understood, but an iron-dependent form of regulated cell death called ferroptosis could be key. Although there is substantial preclinical and clinical evidence that ferroptosis plays a role in NDD, there are still questions regarding how to target ferroptosis therapeutically, including which proteins to target, identification of clinically relevant biomarkers, and which patients might benefit most. Clinical trials of iron- and ferroptosis-targeted therapies are beginning to provide some answers, but there is growing interest in developing new ferroptosis inhibitors. We describe newly identified ferroptosis targets, opportunities, and challenges in NDD, as well as key considerations for progressing new therapeutics to the clinic.Show less >
Show more >Iron accumulation has been associated with the etiology and progression of multiple neurodegenerative diseases (NDDs). The exact role of iron in these diseases is not fully understood, but an iron-dependent form of regulated cell death called ferroptosis could be key. Although there is substantial preclinical and clinical evidence that ferroptosis plays a role in NDD, there are still questions regarding how to target ferroptosis therapeutically, including which proteins to target, identification of clinically relevant biomarkers, and which patients might benefit most. Clinical trials of iron- and ferroptosis-targeted therapies are beginning to provide some answers, but there is growing interest in developing new ferroptosis inhibitors. We describe newly identified ferroptosis targets, opportunities, and challenges in NDD, as well as key considerations for progressing new therapeutics to the clinic.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-01-15T22:29:48Z
2024-06-03T07:57:56Z
2024-06-03T07:57:56Z